Caterina Psarropoulou

Caterina Psarropoulou

Auto-generated profile, based on publicly available information

Caterina Psarropoulou

Laboratory of Animal and Human Physiology, Department of Biological Applications and Technology, Faculty of Health Sciences, University of Ioannina, 45110, Greece

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2014 in Epilepsy Research
Verified
Journal Article
Closed access
PKPanayiotis Kouis
Panayiotis Kouis
AMApostolos Mikroulis
Apostolos Mikroulis
CPCaterina Psarropoulou
Caterina Psarropoulou


29 August 2023 in Epilepsia
Verified
Journal Article
Open access
GMGareth Morris
Gareth Morris
MAMassimo Avoli
Massimo Avoli
CBChristophe Bernard
Christophe Bernard
KCKate Connor
Kate Connor
MCMarco de Curtis
Marco de Curtis
MCMark O. Cunningham
Mark O. Cunningham
In vitro preparations (defined here as cultured cells, brain slices, and isolated whole brains) offer a variety of approaches to modeling various aspects of seizures and epilepsy. Such models are particularly amenable to the application of anti‐seizure compounds, and consequently are a valuable tool to screen the mechanisms of epileptiform activity, mode of action of known anti‐seizure medications (ASMs), and the potential efficacy of putative new anti‐seizure compounds. Despite these applications, all disease models are a simplification of reality and are therefore subject to limitations. In this review, we summarize the main types of in vitro models that can be used in epilepsy research, describing key methodologies as well as notable advantages and disadvantages of each. We argue that a well‐designed battery of in vitro models can form an effective and potentially high‐throughput screening platform to predict the clinical usefulness of ASMs, and that in vitro models are particularly useful for interrogating mechanisms of ASMs. To conclude, we offer several key recommendations that maximize the potential value of in vitro models in ASM screening. This includes the use of multiple in vitro tests that can complement each other, carefully combined with in vivo studies, the use of tissues from chronically epileptic (rather than naïve wild‐type) animals, and the integration of human cell/tissue‐derived preparations.


8 August 2022 in Epilepsia Open
Verified
Journal Article
Open access
KKKonstantinos Kalogeropoulos
Konstantinos Kalogeropoulos
DKDimitrios Kleidonas
Dimitrios Kleidonas
CPCaterina Psarropoulou
Caterina Psarropoulou
Objective: To investigate the effect of generating mechanism on the relationship between interictal‐like epileptiform discharges (IEDs) and the underlying High Frequency Oscillations (HFOs; Ripples, R, and Fast Ripples, FR).Methods: Synchronous spontaneous IEDs were recorded from the CA1 area of hippocampal slices from adult rats, perfused by Mg2+‐free ACSF (n = 41slices/14 animals) or 4‐aminopyridine (50 μM, n = 37slices/16 animals); IED filtering revealed Rs and FRs and several metrics were calculated and compared (amplitude, duration, relative onset, time lag, % overlap, peak frequency, peak power, FR/R).Results: Longer IEDs and higher 1st Population Spike (PS) amplitude in Mg2+‐free ACSF (vs 4‐AP; P < .001, P < .001) correlated with longer duration and higher amplitude Rs (P < .0001, P = .001) and longer duration FRs (P < .001). In both media, Rs and FRs appeared before IED onset with Rs preceding FRs; R‐ and FR‐IED lag (P = .008, P = .01) as well as R‐FR lag (P = .04) were significantly longer in Mg2+‐free ACSF vs in 4‐AP. R peak frequency and power were higher in Mg2+‐free ACSF, while no such differences were observed in FRs. Inter‐model differences were mostly reflected in Rs, not FRs, suggesting that mechanisms unique to R generation are more active in Mg2+‐free ACSF vs in 4‐AP. FRs appeared to contribute equally to IEDs irrespective of generating mechanism.Significance: Several of the metrics used, particularly those regarding the timing between HFOs and IEDs, appear to correlate with the synchronizing mechanism and we propose that they may be useful when investigating antiepileptic substance effects on neuronal network activity.